Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3

PURPOSE: The role of temozolomide chemotherapy alone in isocitrate dehydrogenase (IDH)-mutant astrocytomas has not been conclusively determined. Radiotherapy might be superior to temozolomide. Recent studies have linked temozolomide with induction of hypermutation and poor clinical course in some ID...

Descripción completa

Detalles Bibliográficos
Autores principales: Weller, Jonathan, Katzendobler, Sophie, Blobner, Jens, Thiele, Frederic, Becker, Hannes, Quach, Stefanie, Egensperger, Rupert, Niyazi, Maximilian, Suchorska, Bogdana, Thon, Niklas, Weller, Michael, Tonn, Joerg-Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622511/
https://www.ncbi.nlm.nih.gov/pubmed/36112301
http://dx.doi.org/10.1007/s11060-022-04128-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622511/
https://www.ncbi.nlm.nih.gov/pubmed/36112301
http://dx.doi.org/10.1007/s11060-022-04128-y

Ejemplares similares